Our results suggest that permanent genetic deletion of the glucagon receptor may result in steatosis and hypercholesterolemia and thus highlight glucagon as an important physiological regulator of not just glucose, but also hepatic lipid metabolism. The gene discussed is GCGR; the disease is steatosis.